Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
19.69
-0.21 (-1.08%)
At close: Jun 13, 2025, 4:00 PM
19.68
0.00 (-0.03%)
After-hours: Jun 13, 2025, 4:00 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $506.58 million as of June 13, 2025. Its market cap has increased by 44.18% in one year.
Market Cap
506.58M
Enterprise Value
257.47M
1-Year Change
44.18%
Ranking
Category
Stock Price
$19.69
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $506.58M, an increase of 128.53%. That is a compound annual growth rate of 65.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 511.20M | -1.70% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |